BN Business News
Add your company to Business Communicator →

Business · 17/11/20261 min read

Daewoong Pharmaceutical Presents Phase 1 Clinical Trial Data for New Autoimmune Disease Drug 'Plodicitinib' at ACR Convergence 2026

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

Presented at the American College of Rheumatology (ACR) conference… Confirmed over 90% BTK and ITK target coverage, securing early pharmacodynamic evidence Distinctive mechanism that simultaneously modulates T cells and B cells… Potential for development across a wide range of autoimmune...

Original source language: PR Newswire UK — News ReleasesOpen original release →

Explore insights

Business insights →